Related Experiment Video
Updated: Dec 18, 2025
04:38
Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
Published on: March 28, 2018
16.3K
Update on Emerging Treatment Options for Primary Biliary Cholangitis
Maria T Aguilar1, David M Chascsa2
1Department of Gastroenterology & Hepatology, Mayo Clinic, Scottsdale, AZ, USA.
Hepatic Medicine : Evidence and Research
|June 18, 2020
Summary
Primary biliary cholangitis (PBC) treatments are limited. While ursodeoxycholic acid (UDCA) is first-line, obeticholic acid (OCA) offers adjunct therapy, though pruritus is a concern. Fibrates show promise for PBC management.
Area of Science:
- Hepatology
- Autoimmune Diseases
- Gastroenterology
Background:
- Primary biliary cholangitis (PBC) is a rare autoimmune liver disease.
- It can lead to fibrosis or cirrhosis, with limited treatment options.
- Current therapies include ursodeoxycholic acid (UDCA) and obeticholic acid (OCA).
Purpose of the Study:
- To review current and emerging treatment options for PBC.
- To discuss the efficacy and limitations of existing therapies.
- To explore novel therapeutic strategies for PBC management.
Main Methods:
- Literature review of clinical studies and therapeutic guidelines for PBC.
- Analysis of treatment outcomes for UDCA, OCA, and fibrates.
- Evaluation of symptom management strategies for pruritus and fatigue in PBC.
Main Results:
- UDCA normalizes biochemistries and improves survival in PBC patients.
- OCA serves as an adjunct therapy but may worsen pruritus.
- Fibrates demonstrate promising results in ongoing studies for PBC treatment.
Conclusions:
- Effective management of PBC requires addressing both disease progression and debilitating symptoms.
- Novel therapies like fibrates are under investigation to expand treatment options.
- Further research is needed to optimize PBC treatment and improve patient quality of life.
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
213
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
213
01:17Chronic Bowel Disorders: Introduction
684
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
684
01:29Inflammatory Bowel Disease IV: Pharmacological Management
355
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
355
01:26Peptic Ulcer Disease IV: Management
326
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
326
01:30Acute Pancreatitis II: Clinical Manifestations and Management
611
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
611
01:24Chronic Pancreatitis I: Introduction
594
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
594